| BIOARCTIC AB B |
| Schweden |
| Gesundheit |
| SE0010323311 / A2H5GS |
| B9A (Frankfurt) |
| FRA:B9A, ETR:B9A, B9A:GR |
| - |
| https://www.bioarctic.se/ |
|
BioArctic AB (publ) is a Swedish research-based biopharmaceutical company specializing in disease-modifying treatments for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS. Founded in 2003 by Professor Lars Lannfelt and Dr. PÃ..
>Volltext.. |
| 2550.42 Mio. EUR |
| 2368.66 Mio. EUR |
| 105.71 Mio. EUR |
| - |
| 19.65 Mio. EUR |
| 0.22 EUR |
| 3.75 Mio. EUR |
| 111.02 Mio. EUR |
| 115.49 Mio. EUR |
| 5.12 |
| -24.93% |
| -76.52% |
| 0.18 EUR |
| 0.61% |
| 0.62% |
| 29.05.26 - 0.18454€ 10.05.19 - 0.13599€ |
| - |
| BIOARCTIC |
| 12.07.26 |
|
||||
|
||||
|
||||
|